PDS Biotechnology Stock Price

0.12 (2.27%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 103,146
Bid Price 4.00
Ask Price 5.50
News -
Day High 5.55


52 Week Range


Day Low 5.27
Company Name Stock Ticker Symbol Market Type
PDS Biotechnology Corporation PDSB NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.12 2.27% 5.41 00:00:00
Open Price Low Price High Price Close Price Prev Close
5.32 5.27 5.55 5.41 5.29
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
1,086 103,146 $ 5.39 $ 555,468 - 2.91 - 17.85
Last Trade Time Type Quantity Stock Price Currency
19:36:15 5 $ 5.13 USD


Draw Mode:

PDS Biotechnology Corporation Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 153.96M 28.46M 27.12M $ - $ - -0.64 -5.70
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 204.00k 10.40%

more financials information »

PDS Biotechnology News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical PDSB Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week5.005.8254.905.34380,2720.418.2%
1 Month4.165.8253.624.60314,5281.2530.05%
3 Months5.235.8252.914.19702,2880.183.44%
6 Months6.577.332.914.63467,825-1.16-17.66%
1 Year10.5817.852.917.68452,782-5.17-48.87%
3 Years6.4717.850.61535.37742,774-1.06-16.38%
5 Years8.1617.850.61535.42668,144-2.75-33.7%

PDS Biotechnology Description

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is primarily engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.

Your Recent History
PDS Biotec..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now